Profile
Michael J.
Tolpa is Treasurer & Director at Sanofi AATD, Inc. since 2024 and Treasurer at Provention Bio, Inc. since 2023.
Formerly, Mr. Tolpa was Treasurer at Blueprint Medicines Corp.
and Treasurer at Translate Bio, Inc.
Michael Tolpa active positions
| Companies | Position | Start |
|---|---|---|
| PROVENTION BIO, INC. | Treasurer | 26/04/2023 |
| INHIBRX, INC. | Director/Board Member | 29/05/2024 |
Former positions of Michael Tolpa
| Companies | Position | End |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Director/Board Member | - |
| TRANSLATE BIO, INC. | Treasurer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Translate Bio, Inc.
Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Blueprint Medicines Corp.
Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Provention Bio, Inc.
Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
Inhibrx, Inc.
Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Michael Tolpa
















